Dosing down with biologic therapies: a systematic review and clinicians' perspective

Affiliations

¹ Musculoskeletal Research Unit, NIHR Wellcome Trust Clinical Research Facility, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
² Pierre et Marie Curie University Paris 6, Sorbonne Universités, Pierre Louis Institute of Epidemiology and Public Health, Paris, GRC-08 (EEMOIS).
³ APHP, Rheumatology Department, Pitié Salpêtrière Hospital, Paris, F-75013, France.
⁴ Division of Rheumatology and Clinical Immunology, Department of Medicine IV, Ludwig-Maximilians- Universität, Munich, Germany.
⁵ Department of Rheumatology, Leiden University Medical Center, Leiden, C1-41, The Netherlands.
⁶ Rheumatologisches Schwerpunktzentrum, Munich, Germany.

Published Erratum

Christopher J Edwards et al. Rheumatology (Oxford). 2018.

. 2018 Mar 1;57(3):589.

doi: 10.1093/rheumatology/kex503.

¹ Musculoskeletal Research Unit, NIHR Wellcome Trust Clinical Research Facility, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
² Pierre et Marie Curie University Paris 6, Sorbonne Universités, Pierre Louis Institute of Epidemiology and Public Health, Paris, GRC-08 (EEMOIS).
³ APHP, Rheumatology Department, Pitié Salpêtrière Hospital, Paris, F-75013, France.
⁴ Division of Rheumatology and Clinical Immunology, Department of Medicine IV, Ludwig-Maximilians- Universität, Munich, Germany.
⁵ Department of Rheumatology, Leiden University Medical Center, Leiden, C1-41, The Netherlands.
⁶ Rheumatologisches Schwerpunktzentrum, Munich, Germany.

No abstract available

Erratum for

Dosing down with biologic therapies: a systematic review and clinicians' perspective.
Edwards CJ, Fautrel B, Schulze-Koops H, Huizinga TWJ, Kruger K. Edwards CJ, et al. Rheumatology (Oxford). 2017 Nov 1;56(11):1847-1856. doi: 10.1093/rheumatology/kew464. Rheumatology (Oxford). 2017. PMID: 28339632 Free PMC article.